1. Home
  2. IFN vs BWAY Comparison

IFN vs BWAY Comparison

Compare IFN & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo India Fund Inc. (The)

IFN

India Fund Inc. (The)

HOLD

Current Price

$12.03

Market Cap

540.6M

Sector

Finance

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$16.42

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFN
BWAY
Founded
N/A
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
540.6M
450.8M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
IFN
BWAY
Price
$12.03
$16.42
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.25
AVG Volume (30 Days)
209.2K
144.8K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$309.69
Revenue Next Year
N/A
$26.21
P/E Ratio
N/A
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$10.84
$8.59
52 Week High
$16.60
$26.63

Technical Indicators

Market Signals
Indicator
IFN
BWAY
Relative Strength Index (RSI) 51.71 59.22
Support Level $10.84 $14.56
Resistance Level $12.50 $16.63
Average True Range (ATR) 0.18 0.71
MACD 0.09 0.41
Stochastic Oscillator 64.86 95.83

Price Performance

Historical Comparison
IFN
BWAY

About IFN India Fund Inc. (The)

India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing in the equity securities of Indian companies. The company's portfolio is a non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities, and others. Geographically, all the business activity functions through the market of the United States.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: